العلوم والبيئة
Finding new life in old chemicals for pharmaceuticals using light-driven chemistry
المصدر: Phys.org - latest science and technology news stories · نُشر

Drug companies maintain large libraries of chemical compounds that can be screened for potential use in the development of new pharmaceuticals. One class of these compounds, sulfonamides, is used in antibiotics and in drugs to treat type 2 diabetes, hypertension and inflammation.
Drug companies maintain large libraries of chemical compounds that can be screened for potential use in the development of new pharmaceuticals. One class of these compounds, sulfonamides, is used in antibiotics and in drugs to treat type 2 diabetes, hypertension and inflammation. Thousands of these sulfonamides exist in these libraries, but their use beyond their initial purpose is limited because they are difficult to chemically modify.
أخبار ذات صلة

Thousands of 'off-grid' homes eligible for £250 to help with heating bills
Households dependent on either heating oil or LPG and are eligible for reduced council tax will benefit.
feeds.bbci.co.uk ·

One of the year's most prolific meteor showers visible in the night sky throughout November
The Leonid meteor shower, known for its bright and fast meteors continues through November.
feeds.bbci.co.uk ·

Democrats’ US election sweep brings the price of their promised social contract into focus
‘The post-election wish list is about to run into harsh fiscal reality: there is no money’ Is this an opportunity for a new America? As the Reagan revolution four decades ago launched US society down the path to low taxes and meager solidarity, perhaps the Republican bloodbath la
World news | The Guardian ·

Cheltenham Festival-winning jockey O'Brien dies
Multiple Grade One-winning jockey Tom O’Brien has died at the age of 39.
SkySports | News ·

Man Utd's Pochettino pursuit comes full circle - but would it work?
Mauricio Pochettino and Manchester United have a well-established history. One where paths might have crossed long before now, numerous times, but somehow never managed to converge.
SkySports | News ·